Recursion Pharmaceuticals Inc vs Skyworks Solutions Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Skyworks Solutions Inc trades at $62.99 (market cap $8.99B). The key difference: Skyworks Solutions Inc is far larger — about 5.9× Recursion Pharmaceuticals Inc's market cap, and Skyworks Solutions Inc pays a 4.75% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | SWKS | |
|---|---|---|
Market Cap | $1.53B | $8.99B |
Sector | Health | Technology |
52-Week High | $6.79 | $83.40 |
52-Week Low | $2.84 | $52.50 |
Enterprise Value | $946.50M | $8.76B |
Dividend Yield | — | 4.75% |
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →